By Finance Pulse in INSP —

Inspire Medical Systems Shares Dip 1.4% After FDA Approves Eli Lilly's Zepbound

Inspire Medical Systems stock drops 1.4% as Eli Lilly's Zepbound gains FDA approval, impacting the sleep apnea market.

Illustration of a graph showing a slight dip, with an aesthetic blend of medical and financial eleme
Inspire Medical Systems Shares Dip 1.4% After FDA Approves Eli Lilly's Zepbound

Shares of Inspire Medical Systems fell 1.4% following the FDA's approval of Eli Lilly's Zepbound.

Source